Adam Leo Stone Lian Bio (LIAN) insider trading activity

LIAN Quotes by TradingView

Adam Leo Stone is Interim CEO of LianBio. Currently has a direct ownership of 17,082 shares of LIAN, which is worth approximately $5,124. The most recent transaction as insider was on Feb 15, 2024, when has been sold 19,218 shares (Ordinary Shares) at a price of $4.76 per share, resulting in proceeds of $91,477. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.1K
0% 3M change
n/a 12M change
Total Value Held $5,124

Adam Leo Stone Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 15 2024
SELL
Payment of exercise price or tax liability
$91,477 $4.76 p/Share
19,218 Reduced 52.94%
17,082 Ordinary Shares
Feb 15 2024
BUY
Exercise of conversion of derivative security
$91,476 $2.52 p/Share
36,300 Added 50.0%
36,300 Ordinary Shares

Also insider at

ARYD
ARYA Sciences Acquisition Corp IV Financial Services
Chief Executive Officer
ARYE
ARYA Sciences Acquisition Corp V Financial Services
Chief Executive Officer
SLDB
Solid Biosciences Inc. Healthcare
Director
PCSC
Perceptive Capital Solutions Corp
Chief Executive Officer
ALS

Adam Leo Stone

Interim CEO
New York, NY

Track Institutional and Insider Activities on LIAN

Follow LianBio and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LIAN shares.

Notify only if

Insider Trading

Get notified when an Lian Bio insider buys or sells LIAN shares.

Notify only if

News

Receive news related to LianBio

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LIAN